Literature DB >> 16936798

Interactions of lactoferrin with cells involved in immune function.

Dominique Legrand1, Elisabeth Elass, Mathieu Carpentier, Joël Mazurier.   

Abstract

The antimicrobial activities of lactoferrin (Lf) depend on its capacity to bind iron and on its direct interaction with the surface of microorganisms. Its protective effect also extends to the regulation of the host response to infections. Depending on the immune status of an individual, Lf can have anti-inflammatory properties that downregulate the immune response and prevent septic shock and damage to tissues. It also acts as a promoter of the activation, differentiation, and (or) proliferation of immune cells. Although most of the anti-inflammatory activities are correlated with the neutralization of proinflammatory molecules by Lf, the promoting activity seems to be related to a direct effect of Lf on immune cells. Although the mechanisms that govern these activities are not clearly defined, and probably differ from cell to cell, several cellular targets and possible mechanisms of action are highlighted. The majority of the molecular targets at the surface of cells are multiligand receptors but, interestingly, most of them have been reported as signaling, endocytosis, and nuclear-targeting molecules. This review focuses on the known and putative mechanisms that allow the immunoregulating effect of Lf in its interactions with immune cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936798     DOI: 10.1139/o06-045

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  27 in total

1.  Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression.

Authors:  Jeong-Min Lee; Young-Saeng Jang; Bo-Ra Jin; Sun-Jin Kim; Hyeon-Jin Kim; Bo-Eun Kwon; Hyun-Jeong Ko; Sung-Il Yoon; Geun-Shik Lee; Woan-Sub Kim; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

2.  Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin.

Authors:  Irini Bournazou; John D Pound; Rodger Duffin; Stylianos Bournazos; Lynsey A Melville; Simon B Brown; Adriano G Rossi; Christopher D Gregory
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

3.  Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line.

Authors:  Chiara Pecorini; Davide Sassera; Raffaella Rebucci; Francesca Saccone; Claudio Bandi; Antonella Baldi
Journal:  Vet Res Commun       Date:  2010-03-30       Impact factor: 2.459

Review 4.  Lactoferrin: A Roadmap to the Borderland between Caries and Periodontal Disease.

Authors:  D H Fine
Journal:  J Dent Res       Date:  2015-03-17       Impact factor: 6.116

Review 5.  The role of talactoferrin alpha in the treatment of non-small cell lung cancer.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

Review 6.  New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

7.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

Review 8.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Homologous lactoferrin triggers mobilization of the myelocytic lineage of bone marrow in experimental mice.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocięba; Katarzyna Kaleta-Kuratewicz; Piotr Kuropka; Jan Kuryszko; Marian Kruzel
Journal:  Stem Cells Dev       Date:  2013-08-24       Impact factor: 3.272

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.